CRON strengthens global footprint: Is the cannabis stock worth buying?
Cronos Group CRON continues to attract investor attention as the cannabis company strengthens its global footprint and executes on several strategic initiatives. The company has been expanding its …
Trulieve’s NYSE listing is historic. But is the stock still worth buying?
The listing matters, but fundamentals matter more.
Jim Cramer on Trulieve Cannabis: “I Think It’s a Terrific Spec”
Trulieve Cannabis Corp. (NYSE:TRLV) was among the stocks on which Jim Cramer commented, as he emphasized that SpaceX investors are betting on Elon Musk rather than the company’s earnings. A caller …
Tilray Looks Cheap On The Surface, But Shareholders Still Need Proof
Tilray Brands is rated Hold, trading at a discounted 0.5–0.6x P/S due to persistent unprofitability and dilution risk. Learn more about TLRY stock here.
The 5-minute investor podcast, ep. 65: Cannabis stocks cultivating alpha
Welcome to episode 65 of The 5-Minute Investor Podcast, where Stockhouse columnists Jonathon Brown and me, Trevor Abes, each deliver a 2.5-minute profile on a stock related to recent investment news.
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Jim Cramer on Trulieve Cannabis: “I Think It’s a Terrific Spec”
Trulieve Cannabis Corp. (NYSE:TRLV) was among the stocks on which Jim Cramer commented, as he emphasized that SpaceX investors are betting on Elon Musk rather than the company’s earnings. A caller …
Tilray Looks Cheap On The Surface, But Shareholders Still Need Proof
Tilray Brands is rated Hold, trading at a discounted 0.5–0.6x P/S due to persistent unprofitability and dilution risk. Learn more about TLRY stock here.
The 5-minute investor podcast, ep. 65: Cannabis stocks cultivating alpha
Welcome to episode 65 of The 5-Minute Investor Podcast, where Stockhouse columnists Jonathon Brown and me, Trevor Abes, each deliver a 2.5-minute profile on a stock related to recent investment news.
The First U.S. Marijuana Stock Is Now Trading on the NYSE. Here’s What That Means for Every Cannabis Investor.
Last week, Trulieve Cannabis (OTC: TCNNF) (NYSE:TRLV) became the first U.S. cannabis operator to list on the New York Stock Exchange. The stock is now trading under the symbol “TR …
Trulieve Cannabis to Debut on NYSE After Restructuring, U.S. Marijuana Reclassification
Trulieve Cannabis received regulatory approval to list its shares on the New York Stock Exchange, becoming the first cannabis company cleared to trade on a major U.S. stock exchange.
Cannabis Stocks Are Climbing — And the Biggest Catalyst Hasn’t Even Arrived Yet
Cannabis stocks remain in focus as a key federal hearing approaches, with Green Thumb Industries and Curaleaf among closely watched sector participants.
Why Are NYSE Composite Cannabis Penny Stocks Swinging on Rescheduling?
Cannabis penny stock activity remains volatile as rescheduling discussions, regulatory hearings, and industry developments continue drawing attention across the NYSE Composite.
Cannabis Has Dozens Of Public Companies. Wall Street Acts Like It Has Seven.
Cannabis stocks have rallied 104% in a year, but only seven North American operators clear the institutional threshold that matters to Wall Street.
Why Are Cannabis Stocks Gaining Attention Right Now
Cannabis companies attract renewed attention as reclassification discussions progress and upcoming regulatory proceedings shape expectations across the evolving industry.
Recent Comments